CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

Periodand min./max. price, $	Price change, %		Volatility, %		Volume, $
Periodand min./max. price, $	CSLLY	Industry	CSLLY	Industry	Volume, $
Yesterday 87.9 - 89.5	-5.38	—	—	—	38.07K
Week 87.9 - 89.5	-5.38	—	0.63	—	38.07K
Month 87.9 - 89.5	-5.38	—	1.27	—	38.07K
3 Months 87.9 - 89.5	-5.38	—	1.40	—	38.07K
6 Months 87.9 - 89.5	-5.38	—	1.41	—	38.07K
Year 87.9 - 89.5	-5.38	—	1.41	—	38.07K
All time 84.1 - 105.1	-15.44	—	—	—	76.31M

CSL LTD SP/ADR

Price and volatility history

Risk ratios